News

The research, led by renowned obesity researcher and Phenomix co-founder, Andres Acosta, MD, PhD, and presented by Thomas ...
Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...
Illumina, Inc. (NASDAQ: ILMN), and Ovation.io, Inc., an organization dedicated to building best-in-class multiomics datasets, today announced the development of the largest commercially available ...
Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue ...
A study from Jiangnan University reveals that a gut microbe, Bacteroides vulgatus, can naturally regulate blood sugar levels ...
Mum-of-three Mary lost a substantial amount of weight on Mounjaro - but noticed one significant symptom return as soon as she ...
Researchers in China have found a gut microbe, Bacteroides vulgatus, that may regulate blood sugar. The microbe and its ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Dataset will advance development of GLP-1 therapies in new indications and accelerate discovery of novel drug targets in patients who are unresponsive to therapies "The power of whole-genome and ...
Illumina & Ovation.io launch first-of-kind GLP-1 dataset to accelerate new therapy development: San Diego Saturday, May 3, 2025, 11:00 Hrs [IST] Illumina, Inc., and Ovation.io, In ...